In Vitro Fertilization Outcomes in Metabolic Syndrome

Completed

• Conditions: Metabolic Syndrome

• Registration Number: NCT01958424
• Lead Sponsor: Meir Medical Center

Brief Summary

The purpose of this study is to examine the effect of metabolic syndrome in over-weight women on IVF treatment outcomes.

Detailed Description

This porpuse of the study is to examine the physiology of CRP during the IVF cycle in and to evaluated the effect of CRP in patient with and without metabolic syndrome on IVF outcomes

Study Timeline

• Status Verified: 2013-10
• Study First Submitted: 2013-10-06
• Study First Submitted QC: 2013-10-08
• Study First Posted: 2013-10-09
• Study Start: 2014-04
• Primary Completion: 2014-12
• Study Completion: 2014-12
• Last Update Submitted: 2016-05-10
• Last Update Posted: 2016-05-11

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Female
• Target Recruitment: 30

Inclusion Criteria

• women undergoing ivf treatment

Exclusion Criteria

• inflammatory disease
• acute conditions

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
success or failure of ivf treatment	within 1 year from intiation of ivf treatment	success or failure of a treatment will be determined by beta-Human chorionic gonadotropin test, number of oocyte retrieved or fertilized and embryos quality.

Secondary Outcome Measures

Name	Time	Method
blood levels of C-reactive protein	within 1 year from initiation of ivf treatment
follicle liquid levels of C-reactive protein	within 1 year from initiation of ivf treatment

Trial Locations

Locations (1)

Sapir Medical Center, Meir Hospital; 🇮🇱 Kfar-Saba, Israel